Literature DB >> 26254664

Dynamics of protein aggregation and oligomer formation governed by secondary nucleation.

Thomas C T Michaels1, Hamish W Lazell1, Paolo Arosio1, Tuomas P J Knowles1.   

Abstract

The formation of aggregates in many protein systems can be significantly accelerated by secondary nucleation, a process where existing assemblies catalyse the nucleation of new species. In particular, secondary nucleation has emerged as a central process controlling the proliferation of many filamentous protein structures, including molecular species related to diseases such as sickle cell anemia and a range of neurodegenerative conditions. Increasing evidence suggests that the physical size of protein filaments plays a key role in determining their potential for deleterious interactions with living cells, with smaller aggregates of misfolded proteins, oligomers, being particularly toxic. It is thus crucial to progress towards an understanding of the factors that control the sizes of protein aggregates. However, the influence of secondary nucleation on the time evolution of aggregate size distributions has been challenging to quantify. This difficulty originates in large part from the fact that secondary nucleation couples the dynamics of species distant in size space. Here, we approach this problem by presenting an analytical treatment of the master equation describing the growth kinetics of linear protein structures proliferating through secondary nucleation and provide closed-form expressions for the temporal evolution of the resulting aggregate size distribution. We show how the availability of analytical solutions for the full filament distribution allows us to identify the key physical parameters that control the sizes of growing protein filaments. Furthermore, we use these results to probe the dynamics of the populations of small oligomeric species as they are formed through secondary nucleation and discuss the implications of our work for understanding the factors that promote or curtail the production of these species with a potentially high deleterious biological activity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26254664     DOI: 10.1063/1.4927655

Source DB:  PubMed          Journal:  J Chem Phys        ISSN: 0021-9606            Impact factor:   3.488


  18 in total

1.  Evolutionary Adaptation and Amyloid Formation: Does the Reduced Amyloidogenicity and Cytotoxicity of Ursine Amylin Contribute to the Metabolic Adaption of Bears and Polar Bears?

Authors:  Rehana Akter; Andisheh Abedini; Zachary Ridgway; Xiaoxue Zhang; Joel Kleinberg; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Isr J Chem       Date:  2016-12-19       Impact factor: 3.333

2.  Kinetic diversity of amyloid oligomers.

Authors:  Alexander J Dear; Thomas C T Michaels; Georg Meisl; David Klenerman; Si Wu; Sarah Perrett; Sara Linse; Christopher M Dobson; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-15       Impact factor: 11.205

3.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

4.  Rapid Conversion of Amyloid-Beta 1-40 Oligomers to Mature Fibrils through a Self-Catalytic Bimolecular Process.

Authors:  Bertrand Morel; María P Carrasco-Jiménez; Samuel Jurado; Francisco Conejero-Lara
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

5.  Kinetic Analysis Reveals the Identity of Aβ-Metal Complex Responsible for the Initial Aggregation of Aβ in the Synapse.

Authors:  Thomas Branch; Mauricio Barahona; Charlotte A Dodson; Liming Ying
Journal:  ACS Chem Neurosci       Date:  2017-06-29       Impact factor: 4.418

Review 6.  AFM-Based Single Molecule Techniques: Unraveling the Amyloid Pathogenic Species.

Authors:  Francesco Simone Ruggeri; Johnny Habchi; Andrea Cerreta; Giovanni Dietler
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

7.  Amyloid and the origin of life: self-replicating catalytic amyloids as prebiotic informational and protometabolic entities.

Authors:  Carl Peter J Maury
Journal:  Cell Mol Life Sci       Date:  2018-03-17       Impact factor: 9.261

Review 8.  Mathematical Modeling of Protein Misfolding Mechanisms in Neurological Diseases: A Historical Overview.

Authors:  Felix Carbonell; Yasser Iturria-Medina; Alan C Evans
Journal:  Front Neurol       Date:  2018-02-02       Impact factor: 4.003

9.  Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.

Authors:  Natalia Zamorano Cuervo; Quentin Osseman; Nathalie Grandvaux
Journal:  Viruses       Date:  2018-01-30       Impact factor: 5.048

10.  SAR by kinetics for drug discovery in protein misfolding diseases.

Authors:  Sean Chia; Johnny Habchi; Thomas C T Michaels; Samuel I A Cohen; Sara Linse; Christopher M Dobson; Tuomas P J Knowles; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.